Jpn J Cancer Oncol Res | Volume 1, Issue 1 | Short Communication | Open Access

Precision Oncology: Bridging the Knowledge Gap with Multi-Omics

Angeliki Panagiotara¹, Theodora Katsila^1,2, Minos-Timotheos Matsoukas², George P Patrinos² and Dimitrios Kardamakis^1,3*

¹Department of Radiobiology and Radiation Oncology, University of Patras Medical School, Greece
²Department of Pharmacy, University of Patras, Greece
³Department of Radiation Oncology, University of Patras Medical School, Greece

^*Correspondance to: Dimitrios Kardamakis 

Fulltext PDF

Abstract

The newly-established view in cancer management is that “one size does not fit all”. Every tumour type is a molecularly unique and complex entity, due to inter- and intra-tumour heterogeneity, not only between patients, but in the same patient as well. Diagnostic and therapeutic strategies should be specifically tailored to each patient, however widely accepted criteria for patient stratification and individualizing treatment are still elusive. Undoubtedly, it is time for oncology to move from basic to translational clinical research and multi-omics strategies can pave the way towards this goal by employing a bench-to- bedside attitude.

Keywords:

Omics; Biomarkers; Precision Oncology

Citation:

Panagiotara A, Katsila T, Matsoukas M-T, Patrinos GP, Kardamakis D. Precision Oncology: Bridging the Knowledge Gap with Multi-Omics. Jpn J Cancer Oncol Res. 2018; 1(1): 1003.